Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

31.02USD
11:55am EST
Change (% chg)

$-1.45 (-4.47%)
Prev Close
$32.47
Open
$32.08
Day's High
$32.08
Day's Low
$30.48
Volume
24,220
Avg. Vol
106,525
52-wk High
$34.05
52-wk Low
$20.23

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, production and commercialization of products used in the process of manufacturing biologic drugs (bioprocessing). The Company is a manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing... (more)

Overall

Beta: 1.64
Market Cap(Mil.): $1,098.52
Shares Outstanding(Mil.): 33.83
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 159.64 30.14 30.77
EPS (TTM): 0.20 -- --
ROI: 3.56 15.85 15.23
ROE: 4.80 16.96 16.56

BRIEF-Repligen Q3 non-gaap EPS $0.08

* Revenue for q3 of 2016 increased to $24.7 million compared to $19.8 million for q3 of 2015

Nov 03 2016

BRIEF-Repligen reports Q2 earnings per share $0.11

* Q2 earnings per share view $0.13 -- Thomson Reuters I/B/E/S

Aug 04 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $110.62 -1.43
Novartis AG (NOVN.S) CHF68.75 -0.65
Roche Holding Ltd. (ROG.S) CHF221.20 -2.30
Roche Holding Ltd. (RO.S) CHF225.20 -3.00
Merck & Co., Inc. (MRK.N) $59.83 -0.45
Sanofi SA (SASY.PA) €75.10 -0.45
Amgen, Inc. (AMGN.OQ) $140.63 -4.48
Gilead Sciences, Inc. (GILD.OQ) $72.51 +0.04
Incyte Corporation (INCY.OQ) $103.31 -3.90

Earnings vs. Estimates